Catégories
-
Adhesives
5
Amines
93
Amino Acids
180
Analytical Reagents
664
Antibiotics
251
Bioactive Small Molecules
717
Aroma Chemicals
203
Biochemicals
1004
Boronic Acids
4
Buffers
97
Building Blocks
1770
Carbohydrates
176
Catalysts
97
Chiral Compounds
52
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
250
Flavours and Fragrance Materials
202
Fluorinated Products
42
Furans
5
Gases in Solution
49
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
79
Organics
1294
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
43
Reagents
97
Research Organics & Inorganics
749
Salts
282
Sealing Compounds
1
Sherclin
2
Solvents
121
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
151
Water Analysis
10
Danofloxacin mesylate
(89967722 | 119478-55-6)
CAS: | 119478-55-6 |
---|---|
Formule moléculaire: | C20H24FN3O6S |
Masse moléculaire: | 453.49 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
89967722-1g | 1g | £151.10 | |
Commande en vrac |
89967722-1g | 1g | €211.60 | |
Commande en vrac |
89967722-1g | 1g | $226.70 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 89967722 | ||||
Product Name | Danofloxacin mesylate | ||||
Categories | Antibiotics Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 119478-55-6 | ||||
Molecular Formula | C20H24FN3O6S | ||||
Molecular Weight | 453.49 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2933599590 |
Spécifications du produit
Heavy metals | ≤ 20ppm | ||||
pH | 3.5 - 4.5 | ||||
Loss on Drying | ≤ 5.0% (120°C) | ||||
Assay | ≥ 98.5% | ||||
Related Substances | ≤ 1.5% | ||||
Residue on Ignition | ≤ 0.2% | ||||
Appearance | White to light yellow crystalline powder | ||||
Fluoride | ≥ 3.8% |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|